Bottom line
JAFKX vs FHLC: the short answer
JAFKX (Health Sciences Trust) and FHLC (Fidelity MSCI Health Care Index ETF) are both mutual funds.
FHLC is cheaper at 0.084% vs 1.24% — a difference of $116 a year per $10,000 invested.
Over five years, FHLC returned +7.2% a year vs +3.9% for JAFKX (reporting dates differ).
Updated Nov 19, 2026
JAFKX vs FHLC side by side
| JAFKX | FHLC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | John Hancock | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.24% | 0.084% |
| Annual cost per $10k | $124 | $8.4 |
| 10-yr cost on $10k (prospectus) | $1,510 | $108 |
| Max front load | — | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +19.2% | +2.6% |
| 5-yr return (annualized) | +3.9% | +7.2% |
| 10-yr return (annualized) | +8.5% | +8.8% |
| Best quarter | — | +16.4% |
| Worst quarter | — | −13.1% |
| Net assets (fund) | $251.3M | $3.3B |
| Number of holdings | 173 | 337 |
| Portfolio turnover | 68% | 3% |
| Returns as of | Dec 31, 2025 | Nov 30, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
17 of JAFKX's top 25 holdings also appear in FHLC's top 25.
| Holding | JAFKX | FHLC |
|---|---|---|
| Eli Lilly and Company | 14.30% | 13.35% |
| Johnson and Johnson | 6.33% | 8.93% |
| UnitedHealth Group Incorporated | 5.95% | 5.44% |
| AbbVie Inc. | 5.28% | 6.42% |
| Merck and Co. Inc. | 4.21% | 4.66% |
| Gilead Sciences Inc. | 2.95% | 2.34% |
| Thermo Fisher Scientific Inc. | 2.67% | 3.09% |
| Vertex Pharmaceuticals Incorporated | 2.38% | 1.76% |
| Bristol-Myers Squibb Company | 2.22% | 1.93% |
| Abbott Laboratories | 2.00% | 2.66% |
| Intuitive Surgical Inc. | 1.98% | 1.82% |
| Amgen Inc. | 1.90% | 3.00% |
| Stryker Corporation | 1.87% | 1.62% |
| Elevance Health Inc. | 1.63% | 1.19% |
| Danaher Corporation | 1.51% | 1.80% |
Source: SEC Form N-PORT
JAFKX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
FAQ
What is the difference between JAFKX and FHLC?
JAFKX (Health Sciences Trust) and FHLC (Fidelity MSCI Health Care Index ETF) are both mutual funds. FHLC is cheaper at 0.084% vs 1.24% — a difference of $116 a year per $10,000 invested.
Which is cheaper, JAFKX or FHLC?
FHLC has the lower expense ratio (0.084%).
Should I own both JAFKX and FHLC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.